A quantitative bioassay for HIV-1 gene expression based on UV activation: Effect of glycyrrhizic acid

Antiviral Research

Volumn 62, Issue 1, 2004, Pages 27-36

  Cherng, Jaw Ming ^a   Lin, Hsiung Ju ^b   Hsu, Yung Han ^c   Hung, Man Shan ^c   Lin, Jung Chung ^c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Glycyrrhizic acid; HIV 1 gene expression; UV activation

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS; PROTEIN P50; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL;

ARTICLE; BINDING AFFINITY; BIOASSAY; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BINDING; DRUG EFFECT; ENZYME ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING; ULTRAVIOLET RADIATION;

ANTI-HIV AGENTS; BIOLOGICAL ASSAY; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GLYCYRRHIZIC ACID; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; ULTRAVIOLET RAYS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1542509352     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2003.11.005     Document Type: Article

References (24)

1. Abe N., Ebina T., Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol. Immunol. 26:1982;535-539.
2. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
3. Arase Y., Ikeda K., Murashima N., Chayama K., Tsubota A., Koida I., Suzuki Y., Saitoh S., Kobayashi M., Kumada H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer. 79:1997;1494-1500.
4. Baba M., Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res. 7:1987;99-107.
5. Chen W.Y., Bailey E.C., McCune S.L., Dong J.Y., Townes T.M. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc. Natl. Acad. Sci. USA. 94:1997;5798-5803.
6. Crance J.-M., Leveque F., Biziagos E., van Cuyck-Gandre H., Jouan A., Deloince R. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Antiviral Res. 23:1994;63-76.
7. Devary Y., Rosette C., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 261:1993;1442-1445.
8. Finney R.S.H., Somers G.F. The anti-inflammatory activity of glycyrrhetinic acid and derivatives. J. Pharmacol. 10:1958;613-620.
9. Gorman C.M., Moffat L.F., Howard B.H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
10. Ito M., Nakashima H., Baba M., Pauwels R., De Clercq E., Shigeta E., Yamamoto N. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus (HIV(HTLV-III/LAV)). Antiviral Res. 7:1987;127-137.
11. Ito M., Sato A., Hirabayashi K., Tanabe F., Shigeta S., Baba M., De Clercq E., Nakashima H., Yamamoto N. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res. 10:1988;289-298.
12. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-959.
13. Lin J.-C. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 59:2003;41-47.
14. Numazaki K., Nagata N., Sato T., Chiba S. Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor α on infection of U-937 and MRC-5 cells by human cytomegalovirus. J. Leukocyte Biol. 55:1994;24-28.
15. Pompei R., Flore O., Marccialis M.A., Pani A., Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 281:1979;689-690.
16. Sato H., Goto W., Yamamura J., Kurokawa M., Kageyama S., Takahara T., Watanabe A., Shiraki K. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res. 30:1996;171-177.
17. Shinada M., Azuma M., Kawai H., Sazaki K., Yoshida I., Yoshida T., Suzutani T., Sakuma T. Enhancement of interferon-γ production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus. Proc. Soc. Exp. Biol. Med. 181:1986;205-210.
18. Stein B., Kramer M., Rahmsdorf H.J., Ponta H., Herrlich P. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells. J. Virol. 63:1989;4540-4544.
19. Suzuki H., Ohta Y., Takino T., Fujisawa K., Hirayama D. Effects of glycyrrhizin on biomedical tests in patients with chronic hepatitis - double blind trial. Asian Med. J. 26:1983;423-438.
20. Utsunomiya T., Kobayashi M., Pollard R.B., Suzuki F. Glycyrrhizin, an active component of Licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob. Agents Chemother. 41:1997;551-556.
21. Valerie K., Delers A., Bruck C., Thiriart C., Rosenberg H., Debouck C., Rosenberg M. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 333:1988;78-81.
22. Valerie K., Laster W.S., Kirkham J.C., Kuemmerle N.B. Ionizing radiation activates nuclear factor (B but fails to produce an increase in human immunodeficiency virus gene expression in stably transfected human cells. Biochemistry. 34:1995a;15768-15776.
23. Valerie K., Singhal A., Kirkham J.C., Laster W.S., Rosenberg M. Activation of human immunodeficiency virus gene expression by ultraviolet light in stably transfected human cells does not require the enhancer element. Biochemistry. 34:1995;15760-15767.
24. Woloschak G.E., Panozzo J., Schreck S., Libertin C.R. Salicylic acid inhibits ultraviolet- and cis-platinum-induced human immunodeficiency virus expression. Cancer Res. 55:1995;1696-1700.